SCHEMBL6005698

SCHEMBL6005698

COc1ccc2c(C(=O)c3ccc(OCCC4CCCCCN4)cc3)c(-c3c(F)cccc3F)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.43
ESR1 P03372 6/20 0.37
ESR2 Q92731 6/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HIF1A Q16665 1/20 0.37
PHLPP2 Q6ZVD8 1/20 0.37
SSTR2 P30874 3/20 0.37
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
KDM2B Q8NHM5 1/20 0.35
GCGR P47871 1/20 0.35
AURKB Q96GD4 1/20 0.35
SMYD3 Q9H7B4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6005426 0.99 CHEK2 (0.43) CHEK2ESR1ESR2CYP1A2CYP2D6
SCHEMBL6004611 0.94 CHEK2 (0.43) CHEK2ESR1ESR2CYP1A2CYP2D6
SCHEMBL6004684 0.93 CHEK2 (0.42) CHEK2ESR1ESR2CYP1A2CYP2D6
SCHEMBL6004732 0.93 CHEK2 (0.43) CHEK2ESR1ESR2CYP1A2CYP2D6
SCHEMBL6004724 0.93 CHEK2 (0.43) CHEK2ESR1ESR2CYP1A2CYP2D6
SCHEMBL6003358 0.93 CHEK2 (0.43) CHEK2ESR1ESR2CYP1A2CYP2D6
SCHEMBL6003264 0.92 CHEK2 (0.43) CHEK2ESR1ESR2CYP1A2CYP2D6
SCHEMBL6005869 0.90 CHEK2 (0.44) CHEK2ESR1ESR2SSTR2
SCHEMBL6003300 0.89 CHEK2 (0.43) CHEK2ESR1ESR2CYP1A2CYP2D6
SCHEMBL6005446 0.89 CHEK2 (0.44) CHEK2ESR1ESR2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1709021-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2006-10-11 EP disclosed
WO-2005073204-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2005-08-11 WO disclosed